Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131960) titled 'Efficacy and Safety of Sivelestat Sodium in Patients with Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study' on Sept. 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
Acute ischemic stroke
Intervention:
Placebo control group:Administer a placebo (sodium chloride injection) that matches Xibiqisnate in dosage form, smell, and color
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-09-25
Target Sample Size: Placebo control group:4;Sivelestat Sod...